Omeprazol Farmax (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Farmax, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome in adults and children. GNH USA supplies Omeprazol Farmax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Farmax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors. - Erosive oesophagitis: aids healing of erosive damage to the oesophagus. - NSAID‑associated ulcer prophylaxis: lowers the risk of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools without blood. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild cramping or discomfort. - Flatulence: increased intestinal gas. - Constipation: infrequent, hard stools.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis with watery diarrhoea. - Acute interstitial nephritis: sudden kidney inflammation. - Hypomagnesemia: low blood magnesium levels causing muscle cramps. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction. - Fracture risk: possible reduction in bone mineral density with long‑term use.

When prescribing Omeprazol Farmax, clinicians should consider several safety aspects.

- Assess the need for long‑term therapy: evaluate benefits versus risks for chronic use. - Monitor electrolyte levels: especially magnesium and calcium, during extended treatment. - Review concomitant medications: check for drugs that may interact with acid‑suppression therapy. - Evaluate renal function: adjust use in patients with significant kidney impairment. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, potentially increasing cardiovascular risk. - Atorvastatin: increased plasma concentrations, raising risk of muscle toxicity. - HIV protease inhibitors (e.g., ritonavir): altered drug levels, may require dose adjustment.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect, necessitating INR monitoring. - Methotrex t t t t t t… - Phenytoin: increased metabolism . - Ketamine  …